0	0	1998-09-22	CD	O	O	B-Num
0	1	09	CD	O	O	B-Num
0	2	:	:	O	O	I-Num
0	3	27	CD	O	O	I-Num

1	0	Prostate	JJ	O	B-NP	B-Jour
1	1	cancer	NN	O	I-NP	B-Medical
1	2	is	VBZ	O	B-VP	O
1	3	the	DT	O	B-NP	O
1	4	most	RBS	O	I-NP	O
1	5	diagnosed	VBN	O	I-NP	O
1	6	serious	JJ	O	I-NP	O
1	7	cancer	NN	O	I-NP	B-Medical
1	8	in	IN	O	B-PP	O
1	9	America	NNP	O	B-NP	B-Loc
1	10	;	:	O	O	O
1	11	it	PRP	O	B-NP	O
1	12	is	VBZ	O	B-VP	O
1	13	the	DT	O	B-NP	O
1	14	No.	NN	O	I-NP	O
1	15	2	CD	O	I-NP	B-Num
1	16	cancer-killer	NN	O	I-NP	O
1	17	of	IN	O	B-PP	O
1	18	men	NNS	O	B-NP	O
1	19	;	:	O	O	O
1	20	it	PRP	O	B-NP	O
1	21	kills	VBZ	O	B-VP	O
1	22	African-American	JJ	O	B-NP	O
1	23	men	NNS	O	I-NP	O
1	24	at	IN	O	B-PP	O
1	25	nearly	RB	O	B-NP	O
1	26	twice	RB	O	I-NP	O
1	27	the	DT	O	I-NP	O
1	28	rate	NN	O	I-NP	O
1	29	for	IN	O	B-PP	O
1	30	Caucasian	JJ	O	B-NP	B-LangRace
1	31	men	NNS	O	I-NP	O
1	32	.	.	O	O	O

2	0	Despite	IN	O	B-PP	O
2	1	its	PP$	O	O	O
2	2	lethality	NN	O	O	O
2	3	COMMA	COMMA	O	O	O
2	4	prostate	NN	O	B-NP	B-Jour
2	5	cancer	NN	O	I-NP	B-Medical
2	6	gets	VBZ	O	B-VP	O
2	7	far	RB	O	O	O
2	8	less	RBR	O	O	O
2	9	federal	JJ	O	B-NP	O
2	10	research	NN	O	I-NP	O
2	11	funding	NN	O	I-NP	O
2	12	than	IN	O	O	O
2	13	does	VBZ	O	B-VP	O
2	14	AIDS	NNP	O	B-NP	O
2	15	or	CC	O	O	O
2	16	breast	NN	O	B-NP	O
2	17	cancer	NN	O	I-NP	B-Medical
2	18	.	.	O	O	O

3	0	One	CD	O	B-NP	B-Num
3	1	reason	NN	O	I-NP	O
3	2	is	VBZ	O	B-VP	O
3	3	that	DT	O	O	O
3	4	well-organized	JJ	O	O	O
3	5	lobby	NN	O	O	O
3	6	groups	NNS	O	O	B-OrgCorp
3	7	push	VBP	O	B-VP	O
3	8	for	IN	O	B-PP	O
3	9	funding	VBG	O	B-NP	O
3	10	for	IN	O	B-PP	O
3	11	AIDS	NNP	O	B-NP	O
3	12	and	CC	O	O	O
3	13	breast	NN	O	B-NP	O
3	14	cancer	NN	O	I-NP	B-Medical
3	15	.	.	O	O	O

4	0	Prostate	JJ	O	B-NP	B-Jour
4	1	cancer	NN	O	I-NP	B-Medical
4	2	COMMA	COMMA	O	O	O
4	3	on	IN	O	B-PP	O
4	4	the	DT	O	B-NP	O
4	5	other	JJ	O	I-NP	O
4	6	hand	NN	O	I-NP	O
4	7	COMMA	COMMA	O	O	O
4	8	has	VBZ	O	B-VP	O
4	9	been	VBN	O	I-VP	O
4	10	surrounded	VBN	O	I-VP	O
4	11	by	IN	O	B-PP	O
4	12	an	DT	O	B-NP	O
4	13	aura	NN	O	I-NP	B-Medical
4	14	of	IN	O	B-PP	O
4	15	awkward	JJ	O	B-NP	O
4	16	embarrassment	NN	O	I-NP	O
4	17	COMMA	COMMA	O	O	O
4	18	its	PP$	O	B-NP	O
4	19	victims	NNS	O	I-NP	O
4	20	hushed	VBD	O	B-VP	O
4	21	into	IN	O	B-PP	O
4	22	silence	NN	O	B-NP	O
4	23	by	IN	O	B-PP	O
4	24	the	DT	O	B-NP	O
4	25	biologic	JJ	O	I-NP	O
4	26	reality	NN	O	I-NP	O
4	27	that	IN	O	O	O
4	28	the	DT	O	B-NP	O
4	29	prostate	NN	O	I-NP	B-Jour
4	30	gland	NN	O	I-NP	O
4	31	is	VBZ	O	B-VP	O
4	32	at	IN	O	B-PP	O
4	33	the	DT	O	B-NP	O
4	34	center	NN	O	I-NP	O
4	35	of	IN	O	B-PP	O
4	36	male	JJ	O	B-NP	O
4	37	sexuality	NN	O	I-NP	O
4	38	.	.	O	O	O

5	0	The	DT	O	B-NP	O
5	1	veil	NN	O	I-NP	O
5	2	of	IN	O	B-PP	O
5	3	reticence	NN	O	B-NP	O
5	4	is	VBZ	O	B-VP	O
5	5	starting	VBG	O	I-VP	O
5	6	to	TO	O	I-VP	O
5	7	lift	VB	O	I-VP	O
5	8	COMMA	COMMA	O	O	O
5	9	thanks	NNS	O	B-NP	O
5	10	to	TO	O	B-PP	O
5	11	the	DT	O	B-NP	O
5	12	courageous	JJ	O	I-NP	O
5	13	efforts	NNS	O	I-NP	O
5	14	of	IN	O	B-PP	O
5	15	famous	JJ	O	B-NP	O
5	16	prostate	NN	O	I-NP	B-Jour
5	17	cancer	NN	O	I-NP	B-Medical
5	18	patients	NNS	O	I-NP	O
5	19	like	IN	O	B-PP	O
5	20	Bob	NNP	O	B-NP	B-Peop
5	21	Dole	NNP	O	I-NP	I-Peop
5	22	and	CC	O	O	O
5	23	Norman	NNP	O	B-NP	B-Peop
5	24	Schwarzkopf	NNP	O	I-NP	I-Peop
5	25	COMMA	COMMA	O	O	O
5	26	who	WP	O	B-NP	O
5	27	have	VBP	O	B-VP	O
5	28	made	VBN	O	I-VP	O
5	29	it	PRP	O	B-NP	O
5	30	their	PP$	O	B-NP	O
5	31	personal	JJ	O	I-NP	O
5	32	campaigns	NNS	O	I-NP	O
5	33	to	TO	O	B-VP	O
5	34	alert	VB	O	I-VP	B-Medical
5	35	the	DT	O	B-NP	O
5	36	American	NNP	O	I-NP	B-LangRace
5	37	public	NN	O	I-NP	O
5	38	about	IN	O	B-PP	O
5	39	this	DT	O	B-NP	O
5	40	disease	NN	O	I-NP	B-Medical
5	41	.	.	O	O	O

6	0	The	DT	O	B-NP	O
6	1	Hearst	NNP	O	I-NP	B-Org
6	2	News	NNP	O	I-NP	I-Org
6	3	Service	NNP	O	I-NP	I-Org
6	4	and	CC	O	O	O
6	5	the	DT	O	B-NP	O
6	6	San	NNP	O	I-NP	B-Org
6	7	Antonio	NNP	O	I-NP	I-Org
6	8	Express-News	NNP	O	I-NP	I-Org
6	9	have	VBP	O	B-VP	O
6	10	prepared	VBN	O	I-VP	O
6	11	a	DT	O	B-NP	O
6	12	package	NN	O	I-NP	O
6	13	of	IN	O	B-PP	O
6	14	stories	NNS	O	B-NP	O
6	15	COMMA	COMMA	O	O	O
6	16	photos	NNS	O	B-NP	O
6	17	and	CC	O	I-NP	O
6	18	graphics	NNS	O	I-NP	O
6	19	examining	VBG	O	B-VP	O
6	20	prostate	NN	O	B-NP	B-Jour
6	21	cancer	NN	O	I-NP	B-Medical
6	22	from	IN	O	B-PP	O
6	23	the	DT	O	B-NP	O
6	24	point	NN	O	I-NP	O
6	25	of	IN	O	B-PP	O
6	26	view	VBP	O	B-NP	O
6	27	of	IN	O	B-PP	O
6	28	patients	NNS	O	B-NP	O
6	29	COMMA	COMMA	O	O	O
6	30	physicians	NNS	O	O	B-ProfTitle
6	31	COMMA	COMMA	O	O	O
6	32	researchers	NNS	O	B-NP	B-ProfTitle
6	33	and	CC	O	I-NP	O
6	34	government	NN	O	I-NP	O
6	35	funders	NNS	O	I-NP	O
6	36	.	.	O	O	O

7	0	This	DT	O	B-NP	O
7	1	package	NN	O	I-NP	O
7	2	is	VBZ	O	B-VP	O
7	3	for	IN	O	B-PP	O
7	4	release	NN	O	B-NP	O
7	5	Sept.	NNP	O	B-NP	B-Date
7	6	27	CD	O	I-NP	I-Date
7	7	COMMA	COMMA	O	I-NP	O
7	8	28	CD	O	I-NP	B-Num
7	9	and	CC	O	I-NP	O
7	10	29	CD	O	I-NP	B-Num
7	11	.	.	O	O	O

8	0	The	DT	O	B-NP	O
8	1	photos	NNS	O	I-NP	O
8	2	and	CC	O	I-NP	O
8	3	graphics	NNS	O	I-NP	O
8	4	are	VBP	O	B-VP	O
8	5	available	JJ	O	O	O
8	6	on	IN	O	B-PP	O
8	7	the	DT	O	B-NP	O
8	8	Wieck	NNP	O	I-NP	B-OrgCorp
8	9	Database	NNP	O	I-NP	I-OrgCorp
8	10	.	.	O	O	O

9	0	The	DT	O	B-NP	O
9	1	key	NN	O	I-NP	O
9	2	to	TO	O	B-PP	O
9	3	surviving	VBG	O	B-VP	O
9	4	prostate	NN	O	B-NP	B-Jour
9	5	cancer	NN	O	I-NP	B-Medical
9	6	is	VBZ	O	B-VP	O
9	7	early	JJ	O	B-NP	O
9	8	detection	NN	O	I-NP	B-Medical
9	9	because	IN	O	O	O
9	10	once	RB	O	O	O
9	11	the	DT	O	B-NP	O
9	12	cancer	NN	O	I-NP	B-Medical
9	13	spreads	NNS	O	I-NP	O
9	14	beyond	IN	O	B-PP	O
9	15	the	DT	O	B-NP	O
9	16	prostate	NN	O	I-NP	B-Jour
9	17	gland	NN	O	I-NP	O
9	18	_	NN	O	I-NP	O
9	19	a	DT	O	B-NP	O
9	20	golf-ball-sized	JJ	O	I-NP	O
9	21	organ	NN	O	I-NP	O
9	22	located	VBN	O	B-VP	O
9	23	underneath	IN	O	B-PP	O
9	24	the	DT	O	B-NP	O
9	25	bladder	NN	O	I-NP	O
9	26	_	NN	O	I-NP	O
9	27	a	DT	O	B-NP	O
9	28	cure	NN	O	I-NP	O
9	29	becomes	VBZ	O	B-VP	O
9	30	difficult	JJ	O	O	O
9	31	COMMA	COMMA	O	O	O
9	32	if	IN	O	O	O
9	33	not	RB	O	O	O
9	34	impossible	JJ	O	O	O
9	35	.	.	O	O	O

10	0	Although	IN	O	O	O
10	1	detection	NN	O	B-NP	B-Medical
10	2	tests	NNS	O	I-NP	O
10	3	are	VBP	O	B-VP	O
10	4	simple	JJ	O	O	O
10	5	COMMA	COMMA	O	O	O
10	6	many	JJ	O	O	O
10	7	men	NNS	O	O	O
10	8	don	VB	O	B-VP	O
10	9	't	NN	O	B-NP	O
10	10	get	VB	O	B-VP	O
10	11	tested	VBN	O	I-VP	O
10	12	or	CC	O	O	O
10	13	wait	VBP	O	B-VP	O
10	14	until	IN	O	O	O
10	15	it	PRP	O	B-NP	O
10	16	is	VBZ	O	B-VP	O
10	17	too	RB	O	O	O
10	18	late	JJ	O	O	O
10	19	.	.	O	O	O

11	0	The	DT	O	B-NP	O
11	1	following	VBG	O	I-NP	O
11	2	budget	NN	O	I-NP	O
11	3	outlines	VBZ	O	B-VP	O
11	4	a	DT	O	B-NP	O
11	5	three-day	JJ	O	I-NP	O
11	6	series	NN	O	I-NP	O
11	7	about	IN	O	B-PP	O
11	8	the	DT	O	B-NP	O
11	9	disease	NN	O	I-NP	B-Medical
11	10	.	.	O	O	O

12	0	Our	PP$	O	B-NP	O
12	1	stories	NNS	O	I-NP	O
12	2	deal	VBP	O	B-VP	O
12	3	with	IN	O	B-PP	O
12	4	the	DT	O	B-NP	O
12	5	treatments	NNS	O	I-NP	O
12	6	COMMA	COMMA	O	O	O
12	7	the	DT	O	B-NP	O
12	8	sexual	JJ	O	I-NP	O
12	9	side	NN	O	I-NP	O
12	10	effects	NNS	O	I-NP	O
12	11	of	IN	O	B-PP	O
12	12	treatments	NNS	O	B-NP	O
12	13	COMMA	COMMA	O	O	O
12	14	the	DT	O	B-NP	O
12	15	screening	NN	O	I-NP	O
12	16	procedures	NNS	O	I-NP	O
12	17	COMMA	COMMA	O	O	O
12	18	the	DT	O	B-NP	O
12	19	plight	NN	O	I-NP	O
12	20	of	IN	O	B-PP	O
12	21	African	JJ	O	B-NP	B-LangRace
12	22	American	NNP	O	I-NP	I-LangRace
12	23	men	NNS	O	I-NP	O
12	24	COMMA	COMMA	O	O	O
12	25	the	DT	O	B-NP	O
12	26	politics	NNS	O	I-NP	O
12	27	in	IN	O	B-PP	O
12	28	Washington	NNP	O	B-NP	B-LocCit
12	29	that	IN	O	O	O
12	30	stymie	VB	O	B-VP	O
12	31	prostate	NN	O	B-NP	B-Jour
12	32	cancer	NN	O	I-NP	B-Jour
12	33	research	NN	O	I-NP	I-Jour
12	34	budgets	NNS	O	I-NP	O
12	35	and	CC	O	O	O
12	36	other	JJ	O	B-NP	O
12	37	elements	NNS	O	I-NP	O
12	38	of	IN	O	B-PP	O
12	39	this	DT	O	B-NP	O
12	40	deadly	JJ	O	I-NP	O
12	41	disease	NN	O	I-NP	B-Medical
12	42	.	.	O	O	O

13	0	The	DT	O	B-NP	O
13	1	principal	JJ	O	I-NP	B-ProfTitle
13	2	writer	NN	O	I-NP	B-ProfTitle
13	3	for	IN	O	B-PP	O
13	4	the	DT	O	B-NP	O
13	5	series	NN	O	I-NP	O
13	6	was	VBD	O	B-VP	O
13	7	Eric	NNP	O	B-NP	B-Peop
13	8	Rosenberg	NNP	O	I-NP	I-Peop
13	9	of	IN	O	B-PP	O
13	10	the	DT	O	B-NP	O
13	11	Washington	NNP	O	I-NP	B-LocCit
13	12	bureau	NN	O	I-NP	O
13	13	of	IN	O	B-PP	O
13	14	the	DT	O	B-NP	O
13	15	Hearst	NNP	O	I-NP	O
13	16	Newspapers	NNP	O	I-NP	O
13	17	;	:	O	O	O
13	18	Don	NNP	O	B-NP	B-Peop
13	19	Finley	NNP	O	I-NP	I-Peop
13	20	and	CC	O	O	O
13	21	David	NNP	O	B-NP	B-Peop
13	22	Uhler	NNP	O	I-NP	I-Peop
13	23	of	IN	O	B-PP	O
13	24	The	DT	O	B-NP	O
13	25	Express-News	NNP	O	I-NP	O
13	26	also	RB	O	O	O
13	27	contributed	VBD	O	B-VP	O
13	28	stories	NNS	O	B-NP	O
13	29	.	.	O	O	O

14	0	Graphics	NNP	O	O	O
14	1	by	IN	O	B-PP	O
14	2	Mark	NNP	O	B-NP	B-Peop
14	3	Blackwell	NNP	O	I-NP	I-Peop
14	4	of	IN	O	B-PP	O
14	5	The	DT	O	B-NP	O
14	6	Express-News	NNP	O	I-NP	O
14	7	;	:	O	O	O
14	8	photos	NNS	O	B-NP	O
14	9	by	IN	O	B-PP	O
14	10	Jerry	NNP	O	B-NP	B-Peop
14	11	Lara	NNP	O	I-NP	I-Peop
14	12	of	IN	O	B-PP	O
14	13	The	DT	O	B-NP	O
14	14	Express-News	NNP	O	I-NP	O
14	15	and	CC	O	O	O
14	16	Eric	NNP	O	B-NP	B-Peop
14	17	Rosenberg	NNP	O	I-NP	I-Peop
14	18	.	.	O	O	O

15	0	If	IN	O	O	O
15	1	you	PRP	O	B-NP	O
15	2	have	VBP	O	B-VP	O
15	3	questions	NNS	O	B-NP	O
15	4	about	IN	O	B-PP	O
15	5	stories	NNS	O	B-NP	O
15	6	COMMA	COMMA	O	O	O
15	7	please	VBP	O	B-VP	O
15	8	call	VBP	O	B-VP	O
15	9	Chuck	NNP	O	B-NP	B-Peop
15	10	Lewis	NNP	O	I-NP	I-Peop
15	11	at	IN	O	B-PP	O
15	12	202-298-6920	CD	O	B-NP	B-Num
15	13	.	.	O	O	O

16	0	If	IN	O	O	O
16	1	you	PRP	O	B-NP	O
16	2	have	VBP	O	B-VP	O
16	3	questions	NNS	O	B-NP	O
16	4	about	IN	O	B-PP	O
16	5	photos	NNS	O	B-NP	O
16	6	or	CC	O	I-NP	O
16	7	graphics	NNS	O	I-NP	O
16	8	COMMA	COMMA	O	O	O
16	9	please	VBP	O	B-VP	O
16	10	call	VBP	O	B-VP	O
16	11	Hallie	NNP	O	B-NP	B-Peop
16	12	Paul	NNP	O	I-NP	I-Peop
16	13	at	IN	O	B-PP	O
16	14	210-250-3301	CD	O	B-NP	B-Num
16	15	.	.	O	O	O

17	0	-LBR-	-LBR-	O	O	O
17	1	Note	VB	O	O	O
17	2	:	:	O	O	O
17	3	All	DT	O	B-NP	O
17	4	slugs	NNS	O	I-NP	B-Animal
17	5	contain	VBP	O	B-VP	O
17	6	the	DT	O	B-NP	O
17	7	prefix	NN	O	I-NP	O
17	8	``	``	O	O	O
17	9	PCACOMMA	NNP	O	B-NP	O
17	10	''	''	O	O	O
17	11	the	DT	O	B-NP	O
17	12	medical	JJ	O	I-NP	O
17	13	shorthand	NN	O	I-NP	O
17	14	for	IN	O	B-PP	O
17	15	prostate	NN	O	B-NP	B-Jour
17	16	cancer	NN	O	I-NP	B-Medical
17	17	.	.	O	O	O
17	18	-RBR-	-RBR-	O	O	O

18	0	&	CC	O	O	O
18	1	LR	NNP	O	B-NP	O
18	2	;	:	O	O	O
18	3	&	CC	O	O	O
18	4	QL	NNP	O	B-NP	O
18	5	;	:	O	O	O

19	0	Sunday	NNP	O	B-NP	B-Date
19	1	COMMA	COMMA	O	O	O
19	2	Sept.	NNP	O	B-NP	B-Date
19	3	27	CD	O	I-NP	I-Date
19	4	.	.	O	O	O

20	0	PROSTATE-RDP	NNP	O	B-NP	O
20	1	:	:	O	O	O
20	2	Prostate	NNP	O	B-NP	B-Jour
20	3	cancer	NN	O	I-NP	B-Medical
20	4	is	VBZ	O	B-VP	O
20	5	the	DT	O	B-NP	O
20	6	second-leading	JJ	O	I-NP	O
20	7	cancer-killer	NN	O	I-NP	O
20	8	of	IN	O	B-PP	O
20	9	men	NNS	O	B-NP	O
20	10	COMMA	COMMA	O	O	O
20	11	behind	IN	O	B-PP	O
20	12	lung	NN	O	B-NP	B-Medical
20	13	cancer	NN	O	I-NP	B-Medical
20	14	COMMA	COMMA	O	O	O
20	15	and	CC	O	O	O
20	16	the	DT	O	B-NP	O
20	17	most	RBS	O	I-NP	O
20	18	common	JJ	O	I-NP	O
20	19	non-skin	NN	O	I-NP	O
20	20	cancer	NN	O	I-NP	B-Medical
20	21	diagnosed	VBD	O	B-VP	O
20	22	in	IN	O	B-PP	O
20	23	the	DT	O	B-NP	O
20	24	United	NNP	O	I-NP	B-LocCoun
20	25	States	NNPS	O	I-NP	I-LocCoun
20	26	today	NN	O	I-NP	B-Date
20	27	.	.	O	O	O

21	0	The	DT	O	B-NP	O
21	1	American	NNP	O	I-NP	B-OrgCorp
21	2	Cancer	NNP	O	I-NP	I-OrgCorp
21	3	Society	NNP	O	I-NP	I-OrgCorp
21	4	estimates	VBZ	O	B-VP	O
21	5	184COMMA500	CD	O	B-NP	B-Num
21	6	men	NNS	O	I-NP	O
21	7	will	MD	O	B-VP	O
21	8	be	VB	O	I-VP	O
21	9	diagnosed	VBN	O	I-VP	O
21	10	this	DT	O	B-NP	O
21	11	year	NN	O	I-NP	O
21	12	and	CC	O	O	O
21	13	39COMMA200	CD	O	B-NP	B-Num
21	14	will	MD	O	B-VP	O
21	15	die	VB	O	I-VP	O
21	16	of	IN	O	B-PP	O
21	17	the	DT	O	B-NP	O
21	18	disease	NN	O	I-NP	B-Medical
21	19	COMMA	COMMA	O	O	O
21	20	a	DT	O	B-NP	O
21	21	little	RB	O	I-NP	O
21	22	less	JJR	O	O	O
21	23	than	IN	O	B-PP	O
21	24	the	DT	O	B-NP	O
21	25	number	NN	O	I-NP	O
21	26	of	IN	O	B-PP	O
21	27	deaths	NNS	O	B-NP	O
21	28	from	IN	O	B-PP	O
21	29	breast	NN	O	B-NP	O
21	30	cancer	NN	O	I-NP	B-Medical
21	31	but	CC	O	O	O
21	32	about	RB	O	O	O
21	33	twice	RB	O	O	O
21	34	as	IN	O	O	O
21	35	many	JJ	O	B-NP	O
21	36	deaths	NNS	O	I-NP	O
21	37	from	IN	O	B-PP	O
21	38	AIDs	NNP	O	B-NP	O
21	39	.	.	O	O	O

22	0	Despite	IN	O	B-PP	O
22	1	its	PP$	O	B-NP	O
22	2	toll	NN	O	I-NP	O
22	3	and	CC	O	O	O
22	4	the	DT	O	B-NP	O
22	5	prominence	NN	O	I-NP	O
22	6	of	IN	O	B-PP	O
22	7	some	DT	O	B-NP	O
22	8	of	IN	O	B-PP	O
22	9	its	PP$	O	O	O
22	10	sufferers	NNS	O	O	O
22	11	-LBR-	-LBR-	O	O	O
22	12	Bob	NNP	O	B-NP	B-Peop
22	13	Dole	NNP	O	I-NP	I-Peop
22	14	COMMA	COMMA	O	O	O
22	15	Arnold	NNP	O	B-NP	B-Peop
22	16	Palmer	NNP	O	I-NP	I-Peop
22	17	COMMA	COMMA	O	O	O
22	18	Michael	NNP	O	B-NP	B-Peop
22	19	Milken	NNP	O	I-NP	I-Peop
22	20	COMMA	COMMA	O	O	O
22	21	Andy	NNP	O	B-NP	B-Peop
22	22	Grove	NNP	O	I-NP	I-Peop
22	23	-RBR-	-RBR-	O	O	O
22	24	COMMA	COMMA	O	O	O
22	25	prostate	NN	O	B-NP	B-Jour
22	26	cancer	NN	O	I-NP	B-Medical
22	27	has	VBZ	O	B-VP	O
22	28	received	VBN	O	I-VP	O
22	29	little	JJ	O	B-NP	O
22	30	public	JJ	O	I-NP	O
22	31	attention	NN	O	I-NP	O
22	32	or	CC	O	O	O
22	33	political	JJ	O	B-NP	O
22	34	focus	NN	O	I-NP	O
22	35	.	.	O	O	O

23	0	One	CD	O	B-NP	B-Num
23	1	reason	NN	O	I-NP	O
23	2	:	:	O	O	O
23	3	Men	NNS	O	B-NP	O
23	4	don	VB	O	B-VP	O
23	5	't	NN	O	B-NP	O
23	6	like	IN	O	B-PP	O
23	7	to	TO	O	B-VP	O
23	8	talk	VB	O	I-VP	O
23	9	about	IN	O	B-PP	O
23	10	the	DT	O	B-NP	O
23	11	disease	NN	O	I-NP	B-Medical
23	12	COMMA	COMMA	O	O	O
23	13	which	WDT	O	B-NP	O
23	14	often	RB	O	O	O
23	15	affects	VBZ	O	O	O
23	16	sexual	JJ	O	B-NP	O
23	17	function	NN	O	I-NP	O
23	18	and	CC	O	I-NP	O
23	19	bladder	NN	O	I-NP	O
23	20	control	NN	O	I-NP	O
23	21	.	.	O	O	O

24	0	The	DT	O	B-NP	O
24	1	result	NN	O	I-NP	O
24	2	is	VBZ	O	B-VP	O
24	3	that	IN	O	O	O
24	4	although	IN	O	O	O
24	5	prostate	NN	O	B-NP	B-Jour
24	6	cancer	NN	O	I-NP	B-Medical
24	7	kills	VBZ	O	B-VP	O
24	8	more	JJR	O	B-NP	O
24	9	people	NNS	O	I-NP	O
24	10	than	IN	O	B-PP	O
24	11	AIDs	NNP	O	O	O
24	12	COMMA	COMMA	O	O	O
24	13	research	NN	O	B-NP	O
24	14	on	IN	O	B-PP	O
24	15	prostate	NN	O	B-NP	B-Jour
24	16	cancer	NN	O	I-NP	B-Medical
24	17	gets	VBZ	O	B-VP	O
24	18	only	RB	O	B-NP	O
24	19	a	DT	O	I-NP	O
24	20	fraction	NN	O	I-NP	B-Medical
24	21	of	IN	O	B-PP	O
24	22	the	DT	O	B-NP	O
24	23	federal	JJ	O	I-NP	O
24	24	research	NN	O	I-NP	O
24	25	funding	NN	O	I-NP	O
24	26	that	WDT	O	B-NP	O
24	27	goes	VBZ	O	B-VP	O
24	28	to	TO	O	B-PP	O
24	29	AIDS	NNP	O	B-NP	O
24	30	.	.	O	O	O

25	0	This	DT	O	B-NP	O
25	1	may	MD	O	B-VP	O
25	2	be	VB	O	I-VP	O
25	3	changing	VBG	O	I-VP	O
25	4	as	IN	O	B-PP	O
25	5	a	DT	O	B-NP	O
25	6	result	NN	O	I-NP	O
25	7	of	IN	O	B-PP	O
25	8	an	DT	O	B-NP	O
25	9	emerging	VBG	O	I-NP	O
25	10	grassroots	NNS	O	I-NP	O
25	11	lobbying	VBG	O	I-NP	O
25	12	effort	NN	O	I-NP	O
25	13	coordinated	VBD	O	B-VP	O
25	14	by	IN	O	B-PP	O
25	15	a	DT	O	B-NP	O
25	16	new	JJ	O	I-NP	O
25	17	private	JJ	O	I-NP	O
25	18	organization	NN	O	I-NP	O
25	19	.	.	O	O	O

26	0	By	IN	O	B-PP	O
26	1	ERIC	NNP	O	B-NP	B-Peop
26	2	ROSENBERG	NNP	O	I-NP	I-Peop
26	3	.	.	O	O	O

27	0	-LBR-	-LBR-	O	O	O
27	1	With	IN	O	B-PP	O
27	2	photo	NN	O	B-NP	O
27	3	:	:	O	O	O
27	4	PCA-ROUNDUP	NNP	O	B-NP	O
27	5	.	.	O	O	O
27	6	-RBR-	-RBR-	O	O	O

28	0	SIDEBARS	NNP	O	B-NP	O
28	1	:	:	O	O	O

29	0	PCA-RISK-FACTORS	NNP	O	B-NP	O
29	1	:	:	O	O	O
29	2	While	IN	O	O	O
29	3	little	JJ	O	B-NP	O
29	4	for	IN	O	B-PP	O
29	5	certain	JJ	O	O	O
29	6	is	VBZ	O	B-VP	O
29	7	known	VBN	O	I-VP	O
29	8	about	IN	O	B-PP	O
29	9	what	WP	O	B-NP	O
29	10	causes	VBZ	O	B-VP	O
29	11	prostate	NN	O	B-NP	B-Jour
29	12	cancer	NN	O	I-NP	B-Medical
29	13	COMMA	COMMA	O	O	O
29	14	there	EX	O	B-NP	O
29	15	are	VBP	O	B-VP	O
29	16	two	CD	O	B-NP	B-Num
29	17	groups	NNS	O	I-NP	B-OrgCorp
29	18	of	IN	O	B-PP	O
29	19	men	NNS	O	B-NP	O
29	20	who	WP	O	B-NP	O
29	21	face	VBP	O	B-VP	O
29	22	high	JJ	O	B-NP	O
29	23	risks	NNS	O	I-NP	O
29	24	of	IN	O	B-PP	O
29	25	getting	VBG	O	B-VP	O
29	26	the	DT	O	B-NP	O
29	27	disease	NN	O	I-NP	B-Medical
29	28	:	:	O	O	O
29	29	men	NNS	O	B-NP	O
29	30	over	IN	O	B-PP	O
29	31	65	CD	O	B-NP	B-Num
29	32	years	NNS	O	I-NP	I-Num
29	33	and	CC	O	O	O
29	34	African-American	JJ	O	B-NP	O
29	35	men	NNS	O	I-NP	O
29	36	.	.	O	O	O

30	0	By	IN	O	B-PP	O
30	1	ERIC	NNP	O	B-NP	B-Peop
30	2	ROSENBERG	NNP	O	I-NP	I-Peop
30	3	.	.	O	O	O

31	0	PCA-BLACKS	NNP	O	B-NP	O
31	1	:	:	O	O	O
31	2	For	IN	O	B-PP	O
31	3	mysterious	JJ	O	B-NP	O
31	4	reasons	NNS	O	I-NP	O
31	5	COMMA	COMMA	O	O	O
31	6	a	DT	O	B-NP	O
31	7	perplexing	JJ	O	I-NP	O
31	8	racial	JJ	O	I-NP	O
31	9	element	NN	O	I-NP	O
31	10	haunts	NNS	O	I-NP	O
31	11	prostate	NN	O	I-NP	B-Jour
31	12	cancer	NN	O	I-NP	B-Jour
31	13	research	NN	O	I-NP	I-Jour
31	14	.	.	O	O	O

32	0	Mortality	NN	O	B-NP	O
32	1	rates	NNS	O	I-NP	O
32	2	for	IN	O	B-PP	O
32	3	black	JJ	O	B-NP	B-Color
32	4	Americans	NNPS	O	I-NP	B-LangRace
32	5	are	VBP	O	B-VP	O
32	6	more	JJR	O	B-NP	O
32	7	than	IN	O	O	O
32	8	twice	RB	O	O	O
32	9	as	RB	O	O	O
32	10	high	JJ	O	O	O
32	11	as	IN	O	B-PP	O
32	12	those	DT	O	B-NP	O
32	13	for	IN	O	B-PP	O
32	14	whites	NNS	O	B-NP	O
32	15	.	.	O	O	O

33	0	In	IN	O	B-PP	O
33	1	fact	NN	O	B-NP	O
33	2	COMMA	COMMA	O	O	O
33	3	American	NNP	O	B-NP	B-Org
33	4	blacks	NNS	O	I-NP	O
33	5	have	VBP	O	B-VP	O
33	6	the	DT	O	B-NP	O
33	7	highest	JJS	O	I-NP	O
33	8	prostate	NN	O	I-NP	B-Jour
33	9	cancer	NN	O	I-NP	B-Medical
33	10	rate	NN	O	I-NP	O
33	11	in	IN	O	B-PP	O
33	12	the	DT	O	B-NP	O
33	13	world	NN	O	I-NP	O
33	14	.	.	O	O	O

34	0	By	IN	O	B-PP	O
34	1	ERIC	NNP	O	B-NP	B-Peop
34	2	ROSENBERG	NNP	O	I-NP	I-Peop
34	3	.	.	O	O	O

35	0	-LBR-	-LBR-	O	O	O
35	1	With	IN	O	B-PP	O
35	2	photo	NN	O	B-NP	O
35	3	:	:	O	O	O
35	4	PCA-BLACKS	NNP	O	B-NP	O
35	5	.	.	O	O	O
35	6	-RBR-	-RBR-	O	O	O

36	0	PCA-SEX	NNP	O	B-NP	O
36	1	:	:	O	O	O
36	2	Several	JJ	O	B-NP	O
36	3	top	JJ	O	I-NP	O
36	4	researchers	NNS	O	I-NP	B-ProfTitle
36	5	believe	VBP	O	B-VP	O
36	6	that	IN	O	O	O
36	7	the	DT	O	B-NP	O
36	8	cancer	NN	O	I-NP	B-Medical
36	9	COMMA	COMMA	O	O	O
36	10	at	IN	O	O	O
36	11	least	JJS	O	O	O
36	12	in	IN	O	B-PP	O
36	13	some	DT	O	B-NP	O
36	14	cases	NNS	O	I-NP	O
36	15	COMMA	COMMA	O	O	O
36	16	may	MD	O	B-VP	O
36	17	be	VB	O	I-VP	O
36	18	fomented	VBD	O	I-VP	O
36	19	by	IN	O	B-PP	O
36	20	a	DT	O	B-NP	O
36	21	sexually	RB	O	I-NP	B-Medical
36	22	transmitted	VBN	O	I-NP	I-Medical
36	23	disease	NN	O	I-NP	B-Medical
36	24	found	VBD	O	B-VP	O
36	25	in	IN	O	B-PP	O
36	26	nearly	RB	O	B-NP	O
36	27	two	CD	O	I-NP	B-Num
36	28	out	IN	O	I-NP	O
36	29	of	IN	O	I-NP	O
36	30	three	CD	O	I-NP	B-Num
36	31	American	NNP	O	I-NP	B-LangRace
36	32	men	NNS	O	I-NP	O
36	33	.	.	O	O	O

37	0	By	IN	O	B-PP	O
37	1	ERIC	NNP	O	B-NP	B-Peop
37	2	ROSENBERG	NNP	O	I-NP	I-Peop
37	3	.	.	O	O	O

38	0	PCA-DIAGNOSTIC-TEST	NNP	O	B-NP	O
38	1	:	:	O	O	O
38	2	A	DT	O	B-NP	O
38	3	simple	JJ	O	I-NP	O
38	4	blood	NN	O	I-NP	O
38	5	test	NN	O	I-NP	O
38	6	has	VBZ	O	B-VP	O
38	7	revolutionized	VBD	O	I-VP	O
38	8	prostate	NN	O	B-NP	B-Jour
38	9	medicine	NN	O	I-NP	B-Medical
38	10	by	IN	O	B-PP	O
38	11	diagnosing	VBG	O	B-VP	O
38	12	thousands	NNS	O	B-NP	B-Num
38	13	of	IN	O	B-PP	O
38	14	new	JJ	O	B-NP	O
38	15	cases	NNS	O	I-NP	O
38	16	of	IN	O	B-PP	O
38	17	prostate	NN	O	B-NP	B-Jour
38	18	cancer	NN	O	I-NP	B-Medical
38	19	every	DT	O	B-NP	O
38	20	year	NN	O	I-NP	O
38	21	in	IN	O	B-PP	O
38	22	men	NNS	O	B-NP	O
38	23	who	WP	O	B-NP	O
38	24	have	VBP	O	B-VP	O
38	25	few	JJ	O	O	O
38	26	COMMA	COMMA	O	O	O
38	27	if	IN	O	O	O
38	28	any	DT	O	B-NP	O
38	29	COMMA	COMMA	O	O	O
38	30	other	JJ	O	B-NP	O
38	31	symptoms	NNS	O	I-NP	O
38	32	.	.	O	O	O

39	0	The	DT	O	B-NP	O
39	1	prostate	NN	O	I-NP	B-Jour
39	2	specific	JJ	O	I-NP	O
39	3	antigen	NN	O	I-NP	B-Medical
39	4	-LBR-	-LBR-	O	O	O
39	5	PSA	NNP	O	O	O
39	6	-RBR-	-RBR-	O	O	O
39	7	test	NN	O	B-NP	O
39	8	makes	VBZ	O	B-VP	O
39	9	it	PRP	O	B-NP	O
39	10	possible	JJ	O	O	O
39	11	to	TO	O	B-VP	O
39	12	detect	VB	O	I-VP	O
39	13	tumors	NNS	O	B-NP	O
39	14	before	IN	O	O	O
39	15	they	PRP	O	B-NP	O
39	16	become	VBP	O	B-VP	O
39	17	life-threatening	JJ	O	O	O
39	18	.	.	O	O	O

40	0	By	IN	O	B-PP	O
40	1	ERIC	NNP	O	B-NP	B-Peop
40	2	ROSENBERG	NNP	O	I-NP	I-Peop
40	3	.	.	O	O	O

41	0	GRAPHICS	NNP	O	B-NP	O
41	1	:	:	O	O	O

42	0	PCA-ANATOMY	NNP	O	B-NP	O
42	1	:	:	O	O	O
42	2	graphic	JJ	O	O	O
42	3	showing	VBG	O	O	O
42	4	location	NN	O	B-NP	O
42	5	of	IN	O	B-PP	O
42	6	prostate	NN	O	B-NP	B-Jour
42	7	COMMA	COMMA	O	I-NP	O
42	8	urethra	NN	O	I-NP	O
42	9	COMMA	COMMA	O	O	O
42	10	seminal	JJ	O	B-NP	O
42	11	vesicles	NNS	O	I-NP	O
42	12	COMMA	COMMA	O	O	O
42	13	bladder	NN	O	O	O
42	14	COMMA	COMMA	O	O	O
42	15	rectum	NN	O	B-NP	O
42	16	.	.	O	O	O

43	0	PCA-CELLS	NNP	O	B-NP	O
43	1	:	:	O	O	O
43	2	graphic/slide	NN	O	B-NP	O
43	3	showing	VBG	O	B-VP	O
43	4	a	DT	O	B-NP	O
43	5	cancerous	JJ	O	I-NP	O
43	6	prostate	NN	O	I-NP	B-Jour
43	7	cell	NN	O	I-NP	O
43	8	versus	IN	O	B-PP	O
43	9	a	DT	O	B-NP	O
43	10	healthy	JJ	O	I-NP	O
43	11	one	CD	O	I-NP	B-Num
43	12	.	.	O	O	O

44	0	PCA-MORTALITY-MAP	NNP	O	B-NP	O
44	1	:	:	O	O	O
44	2	state-by-state	JJ	O	B-NP	O
44	3	mortality	NN	O	I-NP	O
44	4	rates	NNS	O	I-NP	O
44	5	:	:	O	O	O
44	6	``	``	O	O	O
44	7	Death	NN	O	B-NP	O
44	8	rates	NNS	O	I-NP	O
44	9	from	IN	O	B-PP	O
44	10	prostate	NN	O	B-NP	B-Jour
44	11	cancer	NN	O	I-NP	B-Medical
44	12	.	.	O	O	O
44	13	''	''	O	O	O

45	0	PCA-RACE-MORT-INCID	NNP	O	B-NP	O
45	1	:	:	O	O	O
45	2	mortality	NN	O	B-NP	O
45	3	rates/incidence	NN	O	I-NP	O
45	4	rates	NNS	O	I-NP	O
45	5	among	IN	O	B-PP	O
45	6	blacks	NNS	O	B-NP	O
45	7	COMMA	COMMA	O	O	O
45	8	Hispanics	NNPS	O	B-NP	B-LangRace
45	9	COMMA	COMMA	O	O	O
45	10	whites	NNS	O	B-NP	O
45	11	and	CC	O	O	O
45	12	other	JJ	O	B-NP	O
45	13	groups	NNS	O	I-NP	B-OrgCorp
45	14	.	.	O	O	O

46	0	PCA-RISING-NUMBERS	NNP	O	B-NP	O
46	1	:	:	O	O	O
46	2	overall	JJ	O	B-NP	O
46	3	incidence	NN	O	I-NP	B-Medical
46	4	rate	NN	O	I-NP	O
46	5	graph	NN	O	I-NP	O
46	6	from	IN	O	B-PP	O
46	7	1973	CD	O	B-NP	B-Date
46	8	through	IN	O	B-PP	O
46	9	1995	CD	O	B-NP	B-Date
46	10	and	CC	O	O	O
46	11	overall	JJ	O	B-NP	O
46	12	mortality	NN	O	I-NP	O
46	13	rate	NN	O	I-NP	O
46	14	graph	NN	O	I-NP	O
46	15	from	IN	O	B-PP	O
46	16	1973-1995	CD	O	B-NP	B-Date
46	17	.	.	O	O	O

47	0	PCA-VICTIMS-SURVIVORS	NNP	O	B-NP	O
47	1	:	:	O	O	O
47	2	Graphic	NNP	O	B-NP	O
47	3	of	IN	O	B-PP	O
47	4	well-known	JJ	O	B-NP	O
47	5	prostate	NN	O	I-NP	B-Jour
47	6	cancer	NN	O	I-NP	B-Medical
47	7	victims	NNS	O	I-NP	O
47	8	.	.	O	O	O

48	0	Monday	NNP	O	B-NP	B-Date
48	1	COMMA	COMMA	O	O	O
48	2	Sept.	NNP	O	B-NP	B-Date
48	3	28	CD	O	I-NP	I-Date
48	4	:	:	O	O	O

49	0	PCA-TREATMENT-OPTIONS	NNP	O	B-NP	O
49	1	:	:	O	O	O
49	2	Prostate	NNP	O	B-NP	B-Jour
49	3	cancer	NN	O	I-NP	B-Medical
49	4	victims	NNS	O	I-NP	O
49	5	face	VBP	O	B-VP	O
49	6	a	DT	O	B-NP	O
49	7	confusing	JJ	O	I-NP	O
49	8	array	NN	O	I-NP	O
49	9	of	IN	O	B-PP	O
49	10	treatment	NN	O	B-NP	O
49	11	options	NNS	O	I-NP	O
49	12	COMMA	COMMA	O	O	O
49	13	all	DT	O	B-NP	O
49	14	carrying	VBG	O	B-VP	O
49	15	the	DT	O	B-NP	O
49	16	risk	NN	O	I-NP	O
49	17	of	IN	O	B-PP	O
49	18	such	JJ	O	B-NP	O
49	19	side	NN	O	I-NP	O
49	20	effects	NNS	O	I-NP	O
49	21	as	IN	O	B-PP	O
49	22	impotence	NN	O	B-NP	B-Medical
49	23	or	CC	O	O	O
49	24	incontinence	VB	O	B-VP	B-Medical
49	25	.	.	O	O	O

50	0	Depending	VBG	O	B-PP	O
50	1	on	IN	O	B-PP	O
50	2	whether	IN	O	O	O
50	3	the	DT	O	B-NP	O
50	4	cancer	NN	O	I-NP	B-Medical
50	5	has	VBZ	O	B-VP	O
50	6	spread	VBN	O	I-VP	O
50	7	beyond	IN	O	B-PP	O
50	8	the	DT	O	B-NP	O
50	9	gland	NN	O	I-NP	O
50	10	COMMA	COMMA	O	O	O
50	11	the	DT	O	B-NP	O
50	12	options	NNS	O	I-NP	O
50	13	may	MD	O	B-VP	O
50	14	include	VB	O	I-VP	O
50	15	:	:	O	O	O

51	0	-	:	O	O	O
51	1	Removal	NNP	O	B-NP	O
51	2	of	IN	O	B-PP	O
51	3	the	DT	O	B-NP	O
51	4	prostate	NN	O	I-NP	B-Jour
51	5	COMMA	COMMA	O	O	O
51	6	a	DT	O	B-NP	O
51	7	prostatectomy	NN	O	I-NP	O
51	8	;	:	O	O	O

52	0	_	NN	O	O	O
52	1	External	NNP	O	O	O
52	2	beam	NN	O	O	O
52	3	radiation	NN	O	O	O
52	4	;	:	O	O	O

53	0	_	NN	O	O	O
53	1	Seed	NN	O	O	O
53	2	radiation	NN	O	O	O
53	3	therapy	NN	O	O	B-Medical
53	4	;	:	O	O	O

54	0	-	:	O	O	O
54	1	Hormonal	NNP	O	O	O
54	2	deprivation	NN	O	O	O
54	3	through	IN	O	B-PP	O
54	4	castration	NN	O	B-NP	B-Medical
54	5	;	:	O	O	O

55	0	-	:	O	O	O
55	1	Chemotherapy	NNP	O	B-NP	B-Jour
55	2	;	:	O	O	O

56	0	_	NN	O	O	O
56	1	Do	VBP	O	B-VP	O
56	2	nothing	NN	O	B-NP	O
56	3	COMMA	COMMA	O	O	O
56	4	the	DT	O	B-NP	O
56	5	``	``	O	I-NP	O
56	6	watchful	JJ	O	I-NP	O
56	7	waiting	NN	O	I-NP	O
56	8	''	''	O	I-NP	O
56	9	approach	NN	O	I-NP	O
56	10	.	.	O	O	O

57	0	We	PRP	O	B-NP	O
57	1	examine	VBP	O	B-VP	O
57	2	each	DT	O	B-NP	O
57	3	treatment	NN	O	I-NP	O
57	4	and	CC	O	O	O
57	5	include	VBP	O	B-VP	O
57	6	commentary	NN	O	B-NP	O
57	7	from	IN	O	B-PP	O
57	8	specialists	NNS	O	B-NP	B-ProfTitle
57	9	around	IN	O	B-PP	O
57	10	the	DT	O	B-NP	O
57	11	country	NN	O	I-NP	O
57	12	and	CC	O	O	O
57	13	the	DT	O	B-NP	O
57	14	personal	JJ	O	I-NP	O
57	15	experiences	NNS	O	I-NP	O
57	16	of	IN	O	B-PP	O
57	17	patients	NNS	O	B-NP	O
57	18	who	WP	O	B-NP	O
57	19	have	VBP	O	B-VP	O
57	20	undergone	VBN	O	I-VP	O
57	21	the	DT	O	B-NP	O
57	22	treatments	NNS	O	I-NP	O
57	23	.	.	O	O	O

58	0	By	IN	O	B-PP	O
58	1	ERIC	NNP	O	B-NP	B-Peop
58	2	ROSENBERG	NNP	O	I-NP	I-Peop
58	3	.	.	O	O	O

59	0	-LBR-	-LBR-	O	O	O
59	1	With	IN	O	B-PP	O
59	2	photos	NNS	O	B-NP	O
59	3	:	:	O	O	O
59	4	PCA-TREATMENT1	NNP	O	B-NP	O
59	5	COMMA	COMMA	O	O	O
59	6	PCA-TREATMENT2	NNP	O	B-NP	B-Loc
59	7	.	.	O	O	O
59	8	-RBR-	-RBR-	O	O	O

60	0	SIDEBARS	NNP	O	B-NP	O
60	1	:	:	O	O	O

61	0	PCA-SURGERY	NNP	O	B-NP	O
61	1	:	:	O	O	O
61	2	The	DT	O	B-NP	O
61	3	surgery	NN	O	I-NP	O
61	4	to	TO	O	B-VP	O
61	5	remove	VB	O	I-VP	O
61	6	the	DT	O	B-NP	O
61	7	patient	NN	O	I-NP	B-Medical
61	8	's	POS	O	B-NP	O
61	9	prostate	NN	O	I-NP	B-Jour
61	10	gland	NN	O	I-NP	O
61	11	gets	VBZ	O	B-VP	O
61	12	underway	NN	O	B-NP	O
61	13	in	IN	O	B-PP	O
61	14	Operating	NNP	O	B-NP	B-Loc
61	15	Room	NNP	O	I-NP	O
61	16	No.	NN	O	I-NP	O
61	17	11	CD	O	I-NP	B-Num
61	18	at	IN	O	B-PP	O
61	19	Walter	NNP	O	B-NP	O
61	20	Reed	NNP	O	I-NP	O
61	21	Army	NNP	O	I-NP	B-OrgPolBody
61	22	Medical	NNP	O	I-NP	B-OrgCorp
61	23	Center	NNP	O	I-NP	B-LocStruct
61	24	in	IN	O	B-PP	O
61	25	Washington	NNP	O	B-NP	B-LocCit
61	26	COMMA	COMMA	O	O	O
61	27	D.C.	NNP	O	B-NP	B-LocStat
61	28	COMMA	COMMA	O	O	O
61	29	at	IN	O	B-PP	O
61	30	8	CD	O	B-NP	B-NumTime
61	31	:	:	O	O	I-NumTime
61	32	30	CD	O	B-NP	I-NumTime
61	33	a.m	RB	O	I-NP	I-NumTime
61	34	.	.	O	O	O

62	0	Surgeons	NNPS	O	B-NP	B-ProfTitle
62	1	make	VBP	O	B-VP	O
62	2	a	DT	O	B-NP	O
62	3	vertical	JJ	O	I-NP	O
62	4	incision	NN	O	I-NP	B-Medical
62	5	about	IN	O	B-NP	O
62	6	five	CD	O	I-NP	B-Num
62	7	inches	NNS	O	I-NP	O
62	8	long	RB	O	O	O
62	9	from	IN	O	B-PP	O
62	10	below	IN	O	B-PP	O
62	11	the	DT	O	B-NP	O
62	12	man	NN	O	I-NP	O
62	13	's	POS	O	B-NP	O
62	14	navel	NN	O	I-NP	O
62	15	to	TO	O	B-PP	O
62	16	the	DT	O	B-NP	O
62	17	base	NN	O	I-NP	O
62	18	of	IN	O	B-PP	O
62	19	his	PP$	O	B-NP	O
62	20	penis	NN	O	I-NP	B-Medical
62	21	.	.	O	O	O

63	0	They	PRP	O	B-NP	O
63	1	slowly	RB	O	O	O
63	2	``	``	O	O	O
63	3	dissect	NN	O	B-NP	O
63	4	down	RB	O	O	O
63	5	''	''	O	O	O
63	6	into	IN	O	B-PP	O
63	7	the	DT	O	B-NP	O
63	8	abdomen	NNS	O	I-NP	B-Medical
63	9	.	.	O	O	O

64	0	By	IN	O	B-PP	O
64	1	ERIC	NNP	O	B-NP	B-Peop
64	2	ROSENBERG	NNP	O	I-NP	I-Peop
64	3	.	.	O	O	O

65	0	-LBR-	-LBR-	O	O	O
65	1	With	IN	O	B-PP	O
65	2	photos	NNS	O	B-NP	O
65	3	:	:	O	O	O
65	4	PCA-McLEOD	NNP	O	B-NP	O
65	5	and	CC	O	I-NP	O
65	6	PCA-GLAND	NNP	O	I-NP	O
65	7	.	.	O	O	O
65	8	-RBR-	-RBR-	O	O	O

66	0	PCA-IMPOTENCY	NNP	O	B-NP	O
66	1	:	:	O	O	O
66	2	The	DT	O	B-NP	O
66	3	most	RBS	O	I-NP	O
66	4	common	JJ	O	I-NP	O
66	5	treatments	NNS	O	I-NP	O
66	6	for	IN	O	B-PP	O
66	7	early-stage	JJ	O	B-NP	O
66	8	prostate	NN	O	I-NP	B-Jour
66	9	cancer	NN	O	I-NP	B-Medical
66	10	_	NN	O	I-NP	O
66	11	surgery	NN	O	I-NP	O
66	12	and	CC	O	I-NP	O
66	13	radiation	NN	O	I-NP	O
66	14	_	NN	O	I-NP	O
66	15	likely	JJ	O	O	O
66	16	will	MD	O	B-VP	O
66	17	reduce	VB	O	I-VP	O
66	18	a	DT	O	B-NP	O
66	19	man	NN	O	I-NP	O
66	20	's	POS	O	B-NP	O
66	21	sexual	JJ	O	I-NP	O
66	22	potency	NN	O	I-NP	B-Medical
66	23	.	.	O	O	O

67	0	The	DT	O	B-NP	O
67	1	treatments	NNS	O	I-NP	O
67	2	can	MD	O	B-VP	O
67	3	pose	VB	O	I-VP	O
67	4	a	DT	O	B-NP	O
67	5	daunting	JJ	O	I-NP	O
67	6	choice	NN	O	I-NP	O
67	7	between	IN	O	B-PP	O
67	8	normal	JJ	O	B-NP	O
67	9	sexual	JJ	O	I-NP	O
67	10	function	NN	O	I-NP	O
67	11	and	CC	O	O	O
67	12	a	DT	O	B-NP	O
67	13	potential	JJ	O	I-NP	O
67	14	cancer	NN	O	I-NP	B-Medical
67	15	cure	NN	O	I-NP	O
67	16	COMMA	COMMA	O	O	O
67	17	between	IN	O	B-PP	O
67	18	quality	NN	O	B-NP	O
67	19	of	IN	O	B-PP	O
67	20	life	NN	O	B-NP	O
67	21	and	CC	O	I-NP	O
67	22	longevity	NN	O	I-NP	O
67	23	.	.	O	O	O

68	0	By	IN	O	B-PP	O
68	1	ERIC	NNP	O	B-NP	B-Peop
68	2	ROSENBERG	NNP	O	I-NP	I-Peop
68	3	.	.	O	O	O

69	0	-LBR-	-LBR-	O	O	O
69	1	With	IN	O	B-PP	O
69	2	photo	NN	O	B-NP	O
69	3	:	:	O	O	O
69	4	PCA-IMPOTENCY	NNP	O	B-NP	O
69	5	.	.	O	O	O
69	6	-RBR-	-RBR-	O	O	O

70	0	PCA-BRACHYTHERAPY	NNP	O	B-NP	O
70	1	_	NN	O	I-NP	O
70	2	Gently	NNP	O	I-NP	O
70	3	COMMA	COMMA	O	O	O
70	4	Dr.	NNP	O	B-NP	B-ProfTitle
70	5	Michael	NNP	O	I-NP	B-Peop
70	6	Sarosdy	NNP	O	I-NP	I-Peop
70	7	slowly	RB	O	B-VP	O
70	8	withdraws	VBZ	O	I-VP	O
70	9	a	DT	O	B-NP	O
70	10	foot-long	JJ	O	I-NP	O
70	11	needle	NN	O	I-NP	O
70	12	from	IN	O	B-PP	O
70	13	between	IN	O	B-PP	O
70	14	Jim	NNP	O	B-NP	B-Peop
70	15	King	NNP	O	I-NP	I-Peop
70	16	's	POS	O	B-NP	I-OrgCorp
70	17	legs	NNS	O	I-NP	O
70	18	.	.	O	O	O

71	0	The	DT	O	B-NP	O
71	1	hollow	JJ	O	I-NP	B-Medical
71	2	probe	NN	O	I-NP	O
71	3	leaves	VBZ	O	B-VP	O
71	4	behind	IN	O	B-PP	O
71	5	a	DT	O	B-NP	O
71	6	tiny	JJ	O	I-NP	O
71	7	trail	NN	O	I-NP	O
71	8	of	IN	O	B-PP	O
71	9	radioactive	JJ	O	B-NP	O
71	10	pellets	NNS	O	I-NP	O
71	11	in	IN	O	B-PP	O
71	12	the	DT	O	B-NP	O
71	13	patient	NN	O	I-NP	B-Medical
71	14	's	POS	O	B-NP	O
71	15	prostate	NN	O	I-NP	B-Jour
71	16	gland	NN	O	I-NP	O
71	17	.	.	O	O	O

72	0	By	IN	O	B-PP	O
72	1	DAVID	NNP	O	B-NP	B-Peop
72	2	UHLER	NNP	O	I-NP	I-Peop
72	3	.	.	O	O	O

73	0	-LBR-	-LBR-	O	O	O
73	1	With	IN	O	B-PP	O
73	2	photo	NN	O	B-NP	O
73	3	:	:	O	O	O
73	4	PCA-KING	NNP	O	B-NP	O
73	5	.	.	O	O	O
73	6	-RBR-	-RBR-	O	O	O

74	0	GRAPHICS	NNP	O	B-NP	O
74	1	:	:	O	O	O

75	0	PCA-CHANCE-DIAG-DEATH	NNP	O	B-NP	O
75	1	:	:	O	O	O
75	2	graphic	JJ	O	O	O
75	3	showing	VBG	O	B-VP	O
75	4	prostate	NN	O	B-NP	B-Jour
75	5	cancer	NN	O	I-NP	B-Medical
75	6	risk	VBP	O	B-VP	O
75	7	increases	NNS	O	B-NP	O
75	8	with	IN	O	B-PP	O
75	9	age	NN	O	B-NP	O
75	10	.	.	O	O	O

76	0	PCA-SIDE-EFFECTS	NNP	O	B-NP	O
76	1	:	:	O	O	O
76	2	graphic	JJ	O	O	O
76	3	explaining	VBG	O	B-VP	O
76	4	current	JJ	O	B-NP	O
76	5	therapies	NNS	O	I-NP	O
76	6	for	IN	O	B-PP	O
76	7	dealing	VBG	O	B-VP	O
76	8	with	IN	O	B-PP	O
76	9	potency	NN	O	B-NP	B-Medical
76	10	side	NN	O	I-NP	O
76	11	effects	NNS	O	I-NP	O
76	12	.	.	O	O	O

77	0	PCA-GLOSSARY	NNP	O	B-NP	O
77	1	:	:	O	O	O
77	2	glossary	NN	O	B-NP	O
77	3	of	IN	O	B-PP	O
77	4	important	JJ	O	B-NP	O
77	5	terms	NNS	O	I-NP	O
77	6	.	.	O	O	O

78	0	PCA-IF-U-R-DIAGNOSED	NNP	O	B-NP	O
78	1	:	:	O	O	O
78	2	Important	JJ	O	B-NP	O
78	3	questions	NNS	O	I-NP	O
78	4	and	CC	O	I-NP	O
78	5	steps	NNS	O	I-NP	O
78	6	to	TO	O	B-VP	O
78	7	take	VB	O	I-VP	O
78	8	if	IN	O	O	O
78	9	diagnosed	VBN	O	B-VP	O
78	10	.	.	O	O	O

79	0	Tuesday	NNP	O	B-NP	B-Date
79	1	Sept.	NNP	O	I-NP	B-Date
79	2	29	CD	O	I-NP	I-Date
79	3	:	:	O	O	O

80	0	PCA-POLITICS	NNP	O	B-NP	O
80	1	:	:	O	O	O
80	2	When	WRB	O	O	O
80	3	Congress	NNP	O	B-NP	B-OrgPolBody
80	4	hands	NNS	O	I-NP	O
80	5	out	IN	O	B-PP	O
80	6	medical	JJ	O	B-NP	O
80	7	research	NN	O	I-NP	O
80	8	money	NN	O	I-NP	B-Money
80	9	COMMA	COMMA	O	O	O
80	10	cash	NN	O	B-NP	O
80	11	flows	NNS	O	I-NP	O
80	12	to	TO	O	B-PP	O
80	13	the	DT	O	B-NP	O
80	14	projects	NNS	O	I-NP	O
80	15	demanded	VBD	O	B-VP	O
80	16	by	IN	O	B-PP	O
80	17	the	DT	O	B-NP	O
80	18	loudest	JJS	O	I-NP	O
80	19	and	CC	O	I-NP	O
80	20	best	RB	O	I-NP	O
80	21	organized	VBN	O	I-NP	O
80	22	health	NN	O	I-NP	O
80	23	lobby	NN	O	I-NP	O
80	24	groups	NNS	O	I-NP	B-OrgCorp
80	25	.	.	O	O	O

81	0	The	DT	O	B-NP	O
81	1	result	NN	O	I-NP	O
81	2	:	:	O	O	O
81	3	Federal	NNP	O	B-NP	O
81	4	research	NN	O	I-NP	O
81	5	spending	NN	O	I-NP	O
81	6	on	IN	O	B-PP	O
81	7	breast	NN	O	B-NP	O
81	8	cancer	NN	O	I-NP	B-Medical
81	9	and	CC	O	O	O
81	10	AIDS	NNP	O	B-NP	O
81	11	far	RB	O	O	O
81	12	exceeds	VBZ	O	B-VP	O
81	13	spending	VBG	O	B-NP	O
81	14	on	IN	O	B-PP	O
81	15	prostate	NN	O	B-NP	B-Jour
81	16	cancer	NN	O	I-NP	B-Jour
81	17	research	NN	O	I-NP	I-Jour
81	18	.	.	O	O	O

82	0	That	DT	O	B-NP	O
82	1	is	VBZ	O	B-VP	O
82	2	starting	VBG	O	I-VP	O
82	3	to	TO	O	I-VP	O
82	4	change	VB	O	I-VP	O
82	5	COMMA	COMMA	O	O	O
82	6	thanks	NNS	O	B-NP	O
82	7	to	TO	O	B-PP	O
82	8	a	DT	O	B-NP	O
82	9	grass-roots	JJ	O	I-NP	O
82	10	lobbying	NN	O	I-NP	O
82	11	effort	NN	O	I-NP	O
82	12	across	IN	O	B-PP	O
82	13	the	DT	O	B-NP	O
82	14	country	NN	O	I-NP	O
82	15	.	.	O	O	O

83	0	By	IN	O	B-PP	O
83	1	ERIC	NNP	O	B-NP	B-Peop
83	2	ROSENBERG	NNP	O	I-NP	I-Peop
83	3	.	.	O	O	O

84	0	-LBR-	-LBR-	O	O	O
84	1	With	IN	O	B-PP	O
84	2	photo	NN	O	B-NP	O
84	3	:	:	O	O	O
84	4	PCA-POLITICS	NNP	O	B-NP	O
84	5	.	.	O	O	O
84	6	-RBR-	-RBR-	O	O	O

85	0	SIDEBARS	NNP	O	B-NP	O
85	1	:	:	O	O	O

86	0	PCA-RESEARCH	NNP	O	B-NP	O
86	1	:	:	O	O	O
86	2	Research	NNP	O	B-NP	B-OrgCorp
86	3	25	CD	O	B-NP	B-Num
86	4	years	NNS	O	I-NP	I-Num
86	5	ago	IN	O	O	O
86	6	on	IN	O	B-PP	O
86	7	sexually	RB	O	B-NP	O
86	8	ambiguous	JJ	O	I-NP	O
86	9	children	NNS	O	I-NP	O
86	10	led	VBD	O	B-VP	O
86	11	to	TO	O	B-PP	O
86	12	the	DT	O	B-NP	O
86	13	drug	NN	O	I-NP	B-Medical
86	14	Proscar	NNP	O	I-NP	O
86	15	COMMA	COMMA	O	O	O
86	16	used	VBD	O	B-VP	O
86	17	to	TO	O	B-VP	O
86	18	treat	VB	O	I-VP	O
86	19	prostate	NN	O	B-NP	B-Jour
86	20	disease	NN	O	I-NP	B-Medical
86	21	and	CC	O	I-NP	O
86	22	male	JJ	O	I-NP	O
86	23	baldness	NN	O	I-NP	B-Medical
86	24	.	.	O	O	O

87	0	Those	DT	O	B-NP	O
87	1	studies	NNS	O	I-NP	O
87	2	identified	VBD	O	B-VP	O
87	3	a	DT	O	B-NP	O
87	4	metabolite	NN	O	I-NP	B-Medical
87	5	of	IN	O	B-PP	O
87	6	testosterone	NN	O	B-NP	O
87	7	now	RB	O	B-VP	O
87	8	being	VBG	O	I-VP	O
87	9	tested	VBN	O	I-VP	O
87	10	to	TO	O	B-VP	O
87	11	find	VB	O	I-VP	O
87	12	a	DT	O	B-NP	O
87	13	drug	NN	O	I-NP	B-Medical
87	14	to	TO	O	B-VP	O
87	15	prevent	VB	O	I-VP	O
87	16	prostate	NN	O	B-NP	B-Jour
87	17	cancer	NN	O	I-NP	B-Medical
87	18	.	.	O	O	O

88	0	By	IN	O	B-PP	O
88	1	DON	NNP	O	B-NP	B-Peop
88	2	FINLEY	NNP	O	I-NP	I-Peop
88	3	.	.	O	O	O

89	0	PCA-NEW-TREATMENTS	NNP	O	B-NP	O
89	1	:	:	O	O	O
89	2	Scientists	NNS	O	B-NP	B-ProfTitle
89	3	are	VBP	O	B-VP	O
89	4	developing	VBG	O	I-VP	O
89	5	an	DT	O	B-NP	O
89	6	array	NN	O	I-NP	O
89	7	of	IN	O	B-PP	O
89	8	new	JJ	O	B-NP	O
89	9	therapies	NNS	O	I-NP	O
89	10	for	IN	O	B-PP	O
89	11	patients	NNS	O	B-NP	O
89	12	who	WP	O	B-NP	O
89	13	fail	VBP	O	B-VP	O
89	14	frontline	NN	O	B-NP	O
89	15	prostate	NN	O	I-NP	B-Jour
89	16	cancer	NN	O	I-NP	B-Medical
89	17	treatments	NNS	O	I-NP	O
89	18	such	JJ	O	B-PP	O
89	19	as	IN	O	I-PP	O
89	20	surgery	NN	O	B-NP	O
89	21	COMMA	COMMA	O	O	O
89	22	radiation	NN	O	B-NP	O
89	23	COMMA	COMMA	O	O	O
89	24	hormonal	JJ	O	B-NP	B-Medical
89	25	blockade	NN	O	I-NP	O
89	26	and	CC	O	I-NP	O
89	27	chemotherapy	NN	O	I-NP	B-Jour
89	28	.	.	O	O	O

90	0	The	DT	O	B-NP	B-OrgCorp
90	1	National	NNP	O	I-NP	I-OrgCorp
90	2	Cancer	NNP	O	I-NP	I-OrgCorp
90	3	Institute	NNP	O	I-NP	I-OrgCorp
90	4	identifies	VBZ	O	B-VP	O
90	5	nearly	RB	O	B-NP	O
90	6	40	CD	O	I-NP	B-Num
90	7	clinical	JJ	O	I-NP	B-Medical
90	8	trials	NNS	O	I-NP	O
90	9	underway	NN	O	O	O
90	10	for	IN	O	B-PP	O
90	11	patients	NNS	O	B-NP	O
90	12	with	IN	O	B-PP	O
90	13	recurrent	JJ	O	B-NP	O
90	14	prostate	NN	O	I-NP	B-Jour
90	15	cancer	NN	O	I-NP	B-Medical
90	16	or	CC	O	I-NP	O
90	17	prostate	NN	O	I-NP	B-Jour
90	18	cancer	NN	O	I-NP	B-Medical
90	19	that	WDT	O	B-NP	O
90	20	has	VBZ	O	B-VP	O
90	21	spread	VBN	O	I-VP	O
90	22	beyond	IN	O	B-PP	O
90	23	the	DT	O	B-NP	O
90	24	gland	NN	O	I-NP	O
90	25	.	.	O	O	O

91	0	We	PRP	O	B-NP	O
91	1	detail	NN	O	B-NP	O
91	2	new	JJ	O	I-NP	O
91	3	prostate	NN	O	I-NP	B-Jour
91	4	cancer	NN	O	I-NP	B-Medical
91	5	treatments	NNS	O	I-NP	O
91	6	under	IN	O	O	O
91	7	study	VBP	O	O	O
91	8	along	IN	O	B-PP	O
91	9	with	IN	O	B-PP	O
91	10	contact	NN	O	B-NP	O
91	11	phone	NN	O	I-NP	O
91	12	numbers	NNS	O	I-NP	O
91	13	.	.	O	O	O

92	0	By	IN	O	B-PP	O
92	1	ERIC	NNP	O	B-NP	B-Peop
92	2	ROSENBERG	NNP	O	I-NP	I-Peop
92	3	.	.	O	O	O

93	0	PCA-MILITARY	NNP	O	B-NP	O
93	1	:	:	O	O	O
93	2	Amid	IN	O	B-PP	O
93	3	a	DT	O	B-NP	O
93	4	network	NN	O	I-NP	O
93	5	of	IN	O	B-PP	O
93	6	laboratories	NNS	O	B-NP	O
93	7	on	IN	O	B-PP	O
93	8	the	DT	O	B-NP	O
93	9	campus	NN	O	I-NP	O
93	10	of	IN	O	B-PP	O
93	11	a	DT	O	B-NP	O
93	12	government	NN	O	I-NP	O
93	13	medical	JJ	O	I-NP	O
93	14	school	NN	O	I-NP	B-OrgUniv
93	15	in	IN	O	B-PP	O
93	16	Bethesda	NNP	O	B-NP	B-Loc
93	17	COMMA	COMMA	O	O	O
93	18	Md.	NNP	O	B-NP	B-LocStat
93	19	COMMA	COMMA	O	O	O
93	20	the	DT	O	B-NP	O
93	21	U.S.	NNP	O	I-NP	B-LocCoun
93	22	military	NN	O	I-NP	O
93	23	is	VBZ	O	B-VP	O
93	24	developing	VBG	O	I-VP	O
93	25	a	DT	O	B-NP	O
93	26	one-of-a-kind	JJ	O	I-NP	O
93	27	tool	NN	O	I-NP	O
93	28	in	IN	O	B-PP	O
93	29	the	DT	O	B-NP	O
93	30	war	NN	O	I-NP	O
93	31	on	IN	O	B-PP	O
93	32	prostate	NN	O	B-NP	B-Jour
93	33	cancer	NN	O	I-NP	B-Medical
93	34	:	:	O	O	O
93	35	a	DT	O	B-NP	O
93	36	massive	JJ	O	I-NP	O
93	37	tissue	NN	O	I-NP	O
93	38	and	CC	O	I-NP	O
93	39	blood	NN	O	I-NP	O
93	40	data	NNS	O	I-NP	O
93	41	base	VBP	O	B-VP	O
93	42	.	.	O	O	O

94	0	By	IN	O	B-PP	O
94	1	ERIC	NNP	O	B-NP	B-Peop
94	2	ROSENBERG	NNP	O	I-NP	I-Peop
94	3	.	.	O	O	O

95	0	-LBR-	-LBR-	O	O	O
95	1	With	IN	O	B-PP	O
95	2	photos	NNS	O	B-NP	O
95	3	:	:	O	O	O
95	4	PCA-MILITARY1-4	NNP	O	B-NP	O
95	5	-RBR-	-RBR-	O	O	O
95	6	.	.	O	O	O

96	0	GRAPHICS	NNP	O	B-NP	O
96	1	:	:	O	O	O

97	0	PCA-RESEARCH	NNP	O	B-NP	O
97	1	DOLLARS	NNPS	O	I-NP	O
97	2	:	:	O	O	O
97	3	graphic	JJ	O	O	O
97	4	of	IN	O	B-PP	O
97	5	federal	JJ	O	B-NP	O
97	6	research	NN	O	I-NP	O
97	7	dollar	NN	O	I-NP	B-Money
97	8	per	IN	O	B-PP	O
97	9	death	NN	O	B-NP	O
97	10	caused	VBN	O	B-VP	O
97	11	by	IN	O	B-PP	O
97	12	prostate	NN	O	B-NP	B-Jour
97	13	cancer	NN	O	I-NP	B-Medical
97	14	COMMA	COMMA	O	O	O
97	15	breast	NN	O	B-NP	O
97	16	cancer	NN	O	I-NP	B-Medical
97	17	and	CC	O	O	O
97	18	AIDs	NNP	O	B-NP	O
97	19	;	:	O	O	O
97	20	graphic	JJ	O	B-NP	O
97	21	of	IN	O	B-PP	O
97	22	federal	JJ	O	B-NP	O
97	23	research	NN	O	I-NP	O
97	24	dollar	NN	O	I-NP	B-Money
97	25	per	IN	O	B-PP	O
97	26	incidence	NN	O	B-NP	B-Medical
97	27	of	IN	O	B-PP	O
97	28	prostate	NN	O	B-NP	B-Jour
97	29	cancer	NN	O	I-NP	B-Medical
97	30	COMMA	COMMA	O	O	O
97	31	breast	NN	O	B-NP	O
97	32	cancer	NN	O	I-NP	B-Medical
97	33	and	CC	O	O	O
97	34	AIDs	NNP	O	B-NP	B-Org
97	35	.	.	O	O	O

98	0	PCA-FOR-MORE-INFO	NNP	O	B-NP	O
98	1	:	:	O	O	O
98	2	listing	NN	O	B-NP	O
98	3	of	IN	O	B-PP	O
98	4	prostate	NN	O	B-NP	B-Jour
98	5	cancer	NN	O	I-NP	B-Medical
98	6	resources	NNS	O	I-NP	O
98	7	COMMA	COMMA	O	O	O
98	8	book	NN	O	B-NP	B-Book
98	9	titles	NNS	O	I-NP	O
98	10	COMMA	COMMA	O	O	O
98	11	Internet	NN	O	B-NP	B-OrgCorp
98	12	sites	NNS	O	I-NP	O
98	13	COMMA	COMMA	O	O	O
98	14	support	VBP	O	B-VP	O
98	15	groups	NNS	O	B-NP	B-OrgCorp
98	16	COMMA	COMMA	O	O	O
98	17	etc	NN	O	B-NP	O
98	18	.	.	O	O	O

99	0	-LBR-	-LBR-	O	O	O
99	1	END	NNP	O	O	B-Org
99	2	-RBR-	-RBR-	O	O	O
